Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal mucosa protection is a complex, multi-layered defense system that safeguards the lining of the GI tract from damage. Key components include the mucus layer (composed of mucins like MUC2, MUC5AC, MUC6), bicarbonate secretion, epithelial cell barrier function, subepithelial blood flow, and immune surveillance. Disruption of these mechanisms can lead to ulcers and inflammation. Therapeutic strategies focus on enhancing these natural defenses using drugs like sucralfate or bismuth compounds, or avoiding damaging agents like NSAIDs.
Various mechanisms including: - Prostaglandin synthesis inhibition (NSAIDs) - Physical barrier reinforcement (Sucralfate, Bismuth) - Stimulation of endogenous prostaglandin release (Sucralfate, Bismuth)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal Mucosa Protection.